Ophthalmology Therapeutics: Does current pipeline innovation hold the potential to affect the future ophthalmology market?

This Frontier Pharma: Ophthalmology Therapeutics assesses first-in-class innovation in the ophthalmology pipeline, highlighting key trends in the distribution of these products.

Pune, India - March 14, 2018 /MarketersMedia/ —

The pipeline is varied in terms of molecular targets and molecule types. Products acting on the immune system and neurotransmitter signaling are the most prevalent, but no single target dominates by any clear margin. There are a total of 194 first-in class pipeline products in development for ophthalmologic indications 38% of the 512 pipeline products for which there is a disclosed molecular target. Encompassing gene therapies, slowing of the visual cycle and antisense therapies, the pipeline appears robust and has huge potential to strengthen treatment options for ophthalmological disorders.

Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-ophthalmology-therapeutics-gene-therapies-and-first-in-class-targets-offer-novel-treatments-for-substantial-unmet-needs-in-a-pipeline-dominated-by-angiogenic-and-immune-signaling-drugs

Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of disease pathogenesis, diagnosis and prognosis, and the treatment options available.
• Visualize the composition of the ophthalmological disorders market in terms of dominant molecule types and targets, and understand the current unmet needs and how they can be addressed. This knowledge allows a competitive understanding of gaps in the market.
• Analyze the ophthalmological disorders pipeline and stratify by stage of development, molecule type and molecular target. There are strong signs in the pipeline that the industry is seeking novel approaches to treating ophthalmological disorders to overcome the overwhelming level of unmet need.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising early-stage targets have been reviewed in greater detail.
• Identify commercial opportunities in the ophthalmological disorders deals landscape by analyzing trends in licensing and co-development deals, and a curated list of ophthalmological disorder therapies that have not yet been involved in deals, and may offer potential investment opportunities.

Get this report at: https://www.themarketreports.com/report/buy-now/935550

In the past the ophthalmological disorders therapy area has suffered from a lack of full understanding of the pathophysiology and underlying mechanisms of the diseases. However, as this knowledge has improved vastly in recent years, potential targets have been identified for treatment. As well as the main disorders previously mentioned, there is also interest in developing treatments for indications such as allergic conjunctivitis and retinitis pigmentosa. The approval of a gene therapy for retinitis pigmentosa is indicative of this progress, and represents the first gene therapy approved for an inherited condition by the FDA.

Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935550

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/ophthalmology-therapeutics-does-current-pipeline-innovation-hold-the-potential-to-affect-the-future-ophthalmology-market/314326

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-ophthalmology-therapeutics-gene-therapies-and-first-in-class-targets-offer-novel-treatments-for-substantial-unmet-needs-in-a-pipeline-dominated-by-angiogenic-and-immune-signaling-drugs%20%20

Source: MarketersMedia

Release ID: 314326

Latest News

Park wins Founders Cup, 54-year-old Davies ties for 2nd

Mar 19, 2018

PHOENIX — Weeks like this at the Founders Cup are why Inbee Park held off retiring and Laura Davies is still competing at age 54. Park celebrated her 19th LPGA Tour victory and first in a little over a year Sunday at Desert Ridge. Davies tied for second for her best tour finish since winning the last of her 20 titles in 2001. Park closed with a 5-under 67 in cool, breezy conditions, pulling away with four straight back-nine birdies. The 29-year-old South Korean star finished at 19-under 269, winning a day after revealing she was 50-50 about retiring before...

The last roars are for Rory McIlroy at Bay Hill

Mar 19, 2018

ORLANDO, Fla. — The connection Rory McIlroy had with Arnold Palmer was strong even before he delivered a Sunday charge that would have made the King proud. McIlroy first played the Arnold Palmer Invitational three years ago, and Palmer teared up at dinner when he asked McIlroy if there was anything he needed and received this reply: "Mr. Palmer, thanks to you, I have everything I could ever need in my life." McIlroy's last victory was at the Tour Championship on Sept. 25, 2016, the day Palmer died. Sunday was special for so many reasons. Tiger Woods brought Bay Hill...

Woods makes a brief run at Bay Hill until a big miss

Mar 19, 2018

ORLANDO, Fla. — Tiger Woods put on a Sunday charge at Bay Hill that looked all too familiar. One swing changed everything at the Arnold Palmer Invitational. Coming off three birdies and two pars saves that brought him to within one shot of the lead, Woods hammered a tee shot so far left on the par-5 16th hole that it went over the fence, into a backyard and out-of-bounds. A birdie or better turned into a bogey, and ultimately it didn't matter when Rory McIlroy closed with five birdies in his last six holes to win. Woods made bogey from...

Final World Cup races called off, Rebensburg wins GS title

Mar 19, 2018

ARE, Sweden — Viktoria Rebensburg won her third season title in the giant slalom on Sunday without hitting the slopes at the World Cup finals. Strong winds forced the cancellation of the season-ending GS while the German skier led the standings by 92 points from world champion Tessa Worley of France, who won the title last season. With a win worth 100 points, Rebensburg was a strong pre-race favorite to wrap up the title. The last men's slalom was also canceled, but that didn't affect the final standings because Marcel Hirscher had already locked up the overall and discipline titles...

As F1 season begins, Schumacher is still fighting far away

Mar 19, 2018

As Formula One drivers prepare for the season-opening Australian Grand Prix next weekend, Michael Schumacher continues a very different fight far away. There remains huge respect for the seven-time F1 champion who, more than four years after a near-fatal brain injury in a skiing accident, is still being cared for at home in the quiet Swiss town of Gland on the shores of Lake Geneva. He's been treated there since September 2014. The thick forest surrounding his castle-like home provides sanctuary from fan and media intrusion with high surrounding walls. While his family fiercely protects his privacy, Schumacher's reputation still...

Broaden News

5 Stars Discovery brings you to the stories from people around the world sharing on the finest luxury resorts, high-end city hotels, and exclusive hideaway to make sure you’ll get the premium experience.

Contact us: sales@starsdiscovery.com